Jonathan Monson - Jun 14, 2021 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
VP, Global Controller and CAO
Signature
/s/ Vance R. Brown, Attorney-in-fact
Stock symbol
BSX
Transactions as of
Jun 14, 2021
Transactions value $
-$385,494
Form type
4
Date filed
6/16/2021, 04:22 PM
Next filing
Jun 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $65.4K +5K +13.49% $13.08 42.1K Jun 14, 2021 Direct F1
transaction BSX Common Stock Sale -$215K -5K -11.89% $42.94 37.1K Jun 14, 2021 Direct F1
transaction BSX Common Stock Options Exercise $102K +7.9K +21.32% $12.89 45K Jun 15, 2021 Direct F1
transaction BSX Common Stock Sale -$338K -7.9K -17.57% $42.78 37.1K Jun 15, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -5K -100% $0.00* 0 Jun 14, 2021 Common Stock 5K $13.08 Direct F1, F3
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -7.9K -44.14% $0.00 10K Jun 15, 2021 Common Stock 7.9K $12.89 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.63 to $42.93, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Grant to the reporting person on February 24, 2014, of an option to purchase 15,000 shares of common stock.
F4 Grant to the reporting person on December 1, 2014, of an option to purchase 17,901 shares of common stock.